SARS Spike Glycoprotein S1 Antibody | 10-626

SARS Spike Glycoprotein S1 Antibody | 10-626 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Virus

Homology: N/A

Immunogen: KLH synthetic peptide derived from SARS spike glycoprotein S1 (101-200/1255)

Research Area: Infectious Disease, COVID-19

Tested Application: E

Application: ELISA (1:500-1000)

Specificiy: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: Purified by Protein A.

Clonality: Polyclonal

Clone: N/A

Isotype: IgG

Conjugate: Unconjugated

Physical State: Liquid

Buffer: 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol

Concentration: 1 mg/mL

Storage Condition: Store at 4˚C short term. Aliquot and store at -20˚C long term. Avoid freeze-thaw cycles.

Alternate Name: SPIKE_CVHSA, Spike glycoprotein, S glycoprotein, E2, Peplomer protein

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus, called SARS-associated coronavirus (SARS-CoV) . Human coronaviruses (HCoVs) were previously only associated with mild diseases. The SARS-CoV genome contains five major open reading frames (ORFs) that encode the replicase polyprotein; the spike (S) , envelope (E) , and membrane (M) glycoproteins; and the nucleocapsid protein (N) .